CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
- Status
- WITHDRAWN
- Phase
- PHASE3
Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- N/A
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
- Status
- COMPLETED
- Phase
- PHASE3
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
- Status
- RECRUITING
- Phase
- PHASE1
Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1
Institut Paoli Calmettes Myelodysplastic Syndromes Database
- Status
- RECRUITING
- Phase
- N/A
Nivolumab With Chemotherapy in Refractory MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)
- Status
- UNKNOWN
- Phase
- PHASE1
Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors
- Status
- TERMINATED
- Phase
- N/A
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS
- Status
- COMPLETED
- Phase
- PHASE1
Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- PHASE4